Roivant Sciences (ROIV) News Today $11.04 +0.20 (+1.85%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ROIV Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period OMERS ADMINISTRATION Corp Decreases Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)OMERS ADMINISTRATION Corp decreased its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 50.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 50,800 shares of the company's stock after selling 50,800 sMay 21 at 4:55 AM | marketbeat.comTyro Capital Management LLC Has $24.94 Million Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV)Tyro Capital Management LLC lifted its stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 20.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,108,283 shares of the company's stock afMay 20 at 7:13 AM | marketbeat.comRafferty Asset Management LLC Increases Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)Rafferty Asset Management LLC grew its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 8.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 722,429 shares of the company's stock afterMay 19 at 6:13 AM | marketbeat.comJefferies Financial Group Inc. Invests $473,000 in Roivant Sciences Ltd. (NASDAQ:ROIV)Jefferies Financial Group Inc. bought a new position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 40,000 shares of the company's stock, valued at approximately $473,000. A number of other institutionalMay 19 at 4:34 AM | marketbeat.comDimensional Fund Advisors LP Sells 71,627 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)Dimensional Fund Advisors LP lessened its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 35.3% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 131,314 shares of the company's stock after selling 71,627 shares during the period. DimMay 18 at 3:05 AM | marketbeat.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Relmada Therapeutics (RLMD) and Roivant Sciences (ROIV)May 17, 2025 | theglobeandmail.comRoivant Sciences Ltd. (NASDAQ:ROIV) Shares Sold by PointState Capital LPPointState Capital LP lessened its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 19.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,297,449 shares of the company's stock afteMay 17, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Holdings Trimmed by Prosight Management LPProsight Management LP trimmed its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 12.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,500,000 shares of the company's stock after selling 221,51May 17, 2025 | marketbeat.comPatient Square Capital LP Has $147.64 Million Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)Patient Square Capital LP increased its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 2.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,480,000 shares of the company's stock after acquiringMay 16, 2025 | marketbeat.comMaven Securities LTD Reduces Stake in Roivant Sciences Ltd. (NASDAQ:ROIV)Maven Securities LTD decreased its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 81.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 75,000 shares of the company's stock afteMay 16, 2025 | marketbeat.com468,010 Shares in Roivant Sciences Ltd. (NASDAQ:ROIV) Acquired by BNP Paribas Financial MarketsBNP Paribas Financial Markets bought a new stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 468,010 shares of the company's stock, valued at approximately $5,537,00May 16, 2025 | marketbeat.comRoivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025 and Provide Business Update on Thursday, May 29, 2025May 15, 2025 | globenewswire.comRoivant Sciences à la conférence BofA Securities : Changements stratégiques et focus sur les litigesMay 15, 2025 | fr.investing.comOCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 32,329 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 22.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 179,266 shares ofMay 15, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Reduces Stake in Roivant Sciences Ltd. (NASDAQ:ROIV)Schonfeld Strategic Advisors LLC reduced its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 79.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 71,400 shares of the company's stock after selling 283,May 11, 2025 | marketbeat.comNorthern Trust Corp Boosts Stake in Roivant Sciences Ltd. (NASDAQ:ROIV)Northern Trust Corp lifted its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 23.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,448,082 shares of the company's stock after acquiring an additional 6May 11, 2025 | marketbeat.comVivek Ramaswamy Sells 273,959 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) StockRoivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) major shareholder Vivek Ramaswamy sold 273,959 shares of the stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $11.47, for a total value of $3,142,309.73. Following the completion of the sale, the insider now directly owns 39,799,611 shares in the company, valued at $456,501,538.17. This represents a 0.68 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own at least 10% of a company's shares are required to disclose their sales and purchases with the SEC.May 11, 2025 | marketbeat.comDME Capital Management LP Sells 36,973 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)DME Capital Management LP lowered its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 0.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,271,067 shares of the company's stock after selling 36,973 sharesMay 10, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Shares Purchased by Caption Management LLCCaption Management LLC raised its stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 1,112.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 150,338 shares of the company's stock afterMay 9, 2025 | marketbeat.comEnvestnet Asset Management Inc. Makes New Investment in Roivant Sciences Ltd. (NASDAQ:ROIV)Envestnet Asset Management Inc. bought a new position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 26,921 shares of the company's stock, valued at approximately $318,000. Several other institutionalMay 9, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Sells 25,367 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)Price T Rowe Associates Inc. MD trimmed its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 9.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 248,264 shares of the company's stock after selling 2May 8, 2025 | marketbeat.com24,000 Shares in Roivant Sciences Ltd. (NASDAQ:ROIV) Acquired by Bellevue Group AGBellevue Group AG bought a new position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm bought 24,000 shares of the company's stock, valued at approximately $284,000. Other institutional investors haMay 7, 2025 | marketbeat.com84,091 Shares in Roivant Sciences Ltd. (NASDAQ:ROIV) Purchased by Raymond James Financial Inc.Raymond James Financial Inc. purchased a new stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 84,091 shares of the company's stock, valued at approximately $995,000. OthMay 7, 2025 | marketbeat.comBaker BROS. Advisors LP Buys 969,057 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)Baker BROS. Advisors LP boosted its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 34.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,767,773 shares of the company's stock after acquirMay 6, 2025 | marketbeat.comRoivant Sciences (NASDAQ:ROIV) Hits New 52-Week High - Time to Buy?Roivant Sciences (NASDAQ:ROIV) Hits New 1-Year High - Here's What HappenedMay 3, 2025 | marketbeat.comRoivant Sciences Ltd. (ROIV): Among David Einhorn’s Stock Picks with Huge Upside PotentialMay 2, 2025 | insidermonkey.comRoivant Sciences Ltd. (ROIV): Among David Einhorn’s Stock Picks with Huge Upside PotentialMay 2, 2025 | msn.comRoivant Sciences Ltd. (NASDAQ:ROIV) Shares Acquired by PDT Partners LLCPDT Partners LLC increased its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 27.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 508,431 shares of the company's stock after purchasing an additiMay 1, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Position Boosted by TOMS Capital Investment Management LPTOMS Capital Investment Management LP lifted its stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 46.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,885,000 shares of the company's stock after buying an additional 1,8May 1, 2025 | marketbeat.comRoivant Sciences Ltd. (ROIV): Among Billionaire Andreas Halvorsen’s Stock Picks With Huge Upside PotentialApril 29, 2025 | insidermonkey.comIntegrated Wealth Concepts LLC Purchases 41,564 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)Integrated Wealth Concepts LLC grew its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 16.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 288,101 shares of the company's stock after purchasing an additional 41,564 sApril 29, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Position Increased by Tower Research Capital LLC TRCTower Research Capital LLC TRC grew its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 816.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 63,458 shares of the company's stock after purchasing an additional 56,534 sApril 29, 2025 | marketbeat.comGilder Gagnon Howe & Co. LLC Acquires Shares of 1,162,986 Roivant Sciences Ltd. (NASDAQ:ROIV)Gilder Gagnon Howe & Co. LLC bought a new position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 1,162,986 shares of the company's stock, valued at approximApril 28, 2025 | marketbeat.comSyon Capital LLC Buys Shares of 22,814 Roivant Sciences Ltd. (NASDAQ:ROIV)Syon Capital LLC purchased a new position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 22,814 shares of the company's stock, valued at approximately $270,000. Other hedge funds have alsoApril 28, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Shares Sold by First Trust Advisors LPFirst Trust Advisors LP trimmed its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 18.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,445,396 shares of the company's stock after seApril 28, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Holdings Increased by Two Seas Capital LPTwo Seas Capital LP lifted its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 4.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,167,807 shares of the company's stock afterApril 27, 2025 | marketbeat.comBarclays PLC Buys 110,371 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)Barclays PLC boosted its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 24.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 569,892 shares of the company's stock after purchasingApril 27, 2025 | marketbeat.comCredit Industriel ET Commercial Invests $1.77 Million in Roivant Sciences Ltd. (NASDAQ:ROIV)Credit Industriel ET Commercial bought a new stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 150,000 shares of the company's stock, valued at approximatelApril 26, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Stock Holdings Lessened by Adage Capital Partners GP L.L.C.Adage Capital Partners GP L.L.C. cut its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 0.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 5,719,983 shares of the company's stock after selling 34,752 shares during the period. Adage CapitaApril 26, 2025 | marketbeat.comInsider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) COO Sells 100,000 Shares of StockRoivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) COO Eric Venker sold 100,000 shares of Roivant Sciences stock in a transaction on Monday, April 21st. The shares were sold at an average price of $10.22, for a total value of $1,022,000.00. Following the transaction, the chief operating officer now owns 1,116,345 shares of the company's stock, valued at $11,409,045.90. The trade was a 8.22 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.April 24, 2025 | marketbeat.comBlackBarn Capital Partners LP Increases Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)BlackBarn Capital Partners LP increased its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 3.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,125,000 shares of the compaApril 24, 2025 | marketbeat.comPeak6 LLC Invests $355,000 in Roivant Sciences Ltd. (NASDAQ:ROIV)Peak6 LLC bought a new stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 30,000 shares of the company's stock, valued at approximately $35April 24, 2025 | marketbeat.comCantor Fitzgerald maintains overweight on Roivant Sciences stockApril 23, 2025 | uk.investing.comRoivant Sciences (NASDAQ:ROIV) Receives "Buy" Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $18.00 target price on shares of Roivant Sciences in a research note on Monday.April 23, 2025 | marketbeat.comRoivant Sciences: Primed For Growth With A De-Risked PipelineApril 23, 2025 | seekingalpha.comL’action de Roivant Sciences maintient un objectif de 18$ malgré un remaniement de directionApril 22, 2025 | fr.investing.comLe président de Roivant Sciences, Eric Venker, vend des actions pour 1,02 millionApril 22, 2025 | fr.investing.comCantor Fitzgerald maintient sa recommandation positive sur l’action Roivant SciencesApril 22, 2025 | fr.investing.comImmunovant Crumbles After Roivant Sweeps Out Its C-Suite, Unveils Strategic ShiftApril 21, 2025 | msn.comImmunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren's Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402April 21, 2025 | globenewswire.com Get Roivant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ROIV and its competitors with MarketBeat's FREE daily newsletter. Email Address ROIV Media Mentions By Week ROIV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ROIV News Sentiment▼1.440.65▲Average Medical News Sentiment ROIV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ROIV Articles This Week▼146▲ROIV Articles Average Week Get Roivant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ROIV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BNTX News Today ONC News Today TEVA News Today SMMT News Today ITCI News Today GMAB News Today RDY News Today VTRS News Today MRNA News Today QGEN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ROIV) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roivant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Roivant Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ROIV Stock Free ROIV Stock Alerts